Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2023 | 4 |
2024 | 3 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Hepatology. 2024 Jan 1;79(1):135-148. doi: 10.1097/HEP.0000000000000542. Epub 2023 Jul 24.
Hepatology. 2024.
PMID: 37505221
Free PMC article.
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
RECOVERY Collaborative Group.
RECOVERY Collaborative Group.
Lancet. 2022 Jul 30;400(10349):359-368. doi: 10.1016/S0140-6736(22)01109-6.
Lancet. 2022.
PMID: 35908569
Free PMC article.
Item in Clipboard
[Argentine Consensus in effective management of anticoagulation clinics for the use of vitamin k antagonists].
Ceresetto JM, Duboscq C, Korin J, Fondevila C, Casais P, Rossi A, Scazziota A, Martinuzzo M, Aris Cancela ME, Rosa C, Pombo G, Guimelli C, Adamczuk Y, Martí A, Penchasky D, Riveros D, Puente D, Celebrin L, Molnar S, Meschengieser S, Castro Ríos M, Blanco A, Hendler H, Brodsky A, Sánchez Luceros A, Negri Aranguren P, Fedele JL, Merlo C, Raña P, Gumpel C, Colorio C, Grand B, Canónico V, Rossi E, Colimodio P, Orlando S, Fassi D, Arias M, Viudez L, Farreras R, Martínez P, Ferro H, Casali C, Baques A, Arbesú G, Viñuales S, Medina F, Cortés V, Gallo MDC, Ehelou L, Barrera L, Rey I, de Larrañaga G, Figueroa F, Vilaseca A, Kuri I, Maneyro A, Otaran M, Xavier DL, Garbiero S, Salviú J, Fontenla P, Eckhardt A, Bomparola C, Fornasiero L.
Ceresetto JM, et al.
Medicina (B Aires). 2020;80 Suppl 4:1-26.
Medicina (B Aires). 2020.
PMID: 32897867
Free article.
Spanish.
Item in Clipboard
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group.
RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, et al.
Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13.
Lancet. 2023.
PMID: 37060915
Free PMC article.
Clinical Trial.
Item in Clipboard
Bictegravir/Emtricitabine/Tenofovir Alafenamide in a Multicentre Cohort: Real-Life Experience From Spain.
Torralba M, Rodríguez G, González Gasca FJ, Cuadra F, Barberá J, Geijo P, Silva A, García MI, Ostaiza MA, García Pérez AM, Arroyo E, Larrubia JR, Gutiérrez A, Porras ML, Calvo Sánchez H, Peña-Asensio J, Arias JG, Mendoza I.
Torralba M, et al.
Ann Pharmacother. 2024 Feb;58(2):140-147. doi: 10.1177/10600280231168852. Epub 2023 May 2.
Ann Pharmacother. 2024.
PMID: 37131300
Item in Clipboard
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group.
RECOVERY Collaborative Group.
Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18.
Lancet Diabetes Endocrinol. 2023.
PMID: 37865101
Free PMC article.
Clinical Trial.
Item in Clipboard
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group.
RECOVERY Collaborative Group.
Lancet Child Adolesc Health. 2024 Mar;8(3):190-200. doi: 10.1016/S2352-4642(23)00316-4. Epub 2024 Jan 22.
Lancet Child Adolesc Health. 2024.
PMID: 38272046
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite